| Radoslav Toshkoff, DO | |
|
175 Memorial Hwy, Suite 1-2, New Rochelle, NY 10801-5635 | |
| (914) 633-6375 | |
| (914) 633-6359 |
| Full Name | Radoslav Toshkoff |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 21 Years |
| Location | 175 Memorial Hwy, New Rochelle, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063697027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 246638 (New York) | Primary |
| Entity Name | New York City Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208127 PECOS PAC ID: 4183535305 Enrollment ID: O20040322001521 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In October 2011 the National Institute of Justice (NIJ) and the Forensic Science Foundation (FSF) funded a capstone project proposal in the Master of Forensic Science Program at Sam Houston State University to investigate the designer drugs known as "Bath Salts."
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
› Verified 6 days ago
| Entity Name | Toshkoff Ent Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821373358 PECOS PAC ID: 6002051893 Enrollment ID: O20130327000304 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In October 2011 the National Institute of Justice (NIJ) and the Forensic Science Foundation (FSF) funded a capstone project proposal in the Master of Forensic Science Program at Sam Houston State University to investigate the designer drugs known as "Bath Salts."
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Radoslav Toshkoff, DO 175 Memorial Hwy, Suite 1-2, New Rochelle, NY 10801-5635 Ph: (914) 633-6375 | Radoslav Toshkoff, DO 175 Memorial Hwy, Suite 1-2, New Rochelle, NY 10801-5635 Ph: (914) 633-6375 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In October 2011 the National Institute of Justice (NIJ) and the Forensic Science Foundation (FSF) funded a capstone project proposal in the Master of Forensic Science Program at Sam Houston State University to investigate the designer drugs known as "Bath Salts."
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: inflammatory arthritis and autoimmune disease.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
› Verified 6 days ago
Dr. Jefffrey Howard Belmont, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 41 Lockwood Ave, New Rochelle, NY 10801 Phone: 212-517-8299 | |
Dr. David J Mener, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 145 Huguenot St Ste 610, New Rochelle, NY 10801 Phone: 914-235-1888 Fax: 914-235-1896 | |
Dr. Anthony Joseph Reino, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 175 Memorial Hwy, Suite 1-2, New Rochelle, NY 10801 Phone: 914-633-6375 Fax: 914-633-6359 | |
Dr. Jeffrey Stephan Stier, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 16 Guion Pl, Sound Shore Medical Center Of Westchester, New Rochelle, NY 10801 Phone: 914-637-1186 | |
Dr. Derek K Soohoo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 145 Huguenot St Ste 610, New Rochelle, NY 10801 Phone: 914-235-1888 | |
Dr. Matthew Jonathan Kates, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 145 Huguenot St Ste 610, New Rochelle, NY 10801 Phone: 914-235-1888 Fax: 914-235-1896 |